Fundamentals of MR spectroscopy

Clinical MR Neuroimaging: Physiological and Functional Techniques, Second Edition

Volumn , Issue , 2011, Pages 5-20

  Barker, Peter B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ANALYSIS; CHEMICAL SHIFT; FREQUENCY DOMAIN ANALYSIS; MAGNETIC AFTER EFFECT; MAGNETIC FIELD EFFECTS; MOLECULES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SIGNAL PROCESSING; SUPERCONDUCTING MAGNETS;

CHEMICAL AND BIOLOGICALS; CHEMICAL ENVIRONMENT; MULTIDIMENSIONAL NMR; NUCLEAR MAGNETIC RESONANCE (NMR); RADIO FREQUENCY TRANSMITTERS; RESONANCE FREQUENCIES; STRONG MAGNETIC FIELDS; STRUCTURE ELUCIDATION;

TIME DOMAIN ANALYSIS;

EID: 85011325143     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139193481.004     Document Type: Chapter

References (98)

1. Purcell EM, Torrey HC, Pound RV. Resonance absorption by nuclearmagneticmoments in a solid. Phys Rev 1946; 69: 37-38.
2. Bloch F. Nuclear induction. Phys Rev 1946; 70: 460-474.
3. Proctor WG, Yu FC. The dependence of a nuclear magnetic resonance frequency. Phys Rev 1950; 77: 717.
4. Gutowsky HS, McCall DW. Nuclear magnetic resonance fine structure in liquids. Phys Rev 1951; 82: 748-749.
5. Radda GK. The use of NMR spectroscopy for the understanding of disease. Science 1986; 233: 640-645.
6. 31P NMR spectroscopy. Magn Reson Med 1989; 11: 1-21.
7. Arnold DL, Shoubridge EA, Emrich J, Feindel W, Villemure JG. Early metabolic changes following chemotherapy of human gliomas in vivo demonstrated by phosphorus magnetic resonance spectroscopy. Invest Radiol 1989; 24: 958-961.
8. Levine SR, Helpern JA, Welch KM, et al. Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy. Radiology 1992; 185: 537-544.
9. Frahm J, Bruhn H, Gyngell ML, et al. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989; 9: 79-93.
10. 1H NMR spectra of human brain in vivo. NMR Biomed 1991; 4: 201-204.
11. Barker PB. N-Acetyl aspartate: a neuronal marker? Ann Neurol 2001; 49: 423-424.
12. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetylaspartate with monoclonal antibodies. Neuroscience 1991; 45: 37-45.
13. De Stefano N, Narayanan S, Francis GS, et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001; 58: 65-70.
14. 1H nuclearmagnetic resonance spectroscopic imaging of neuronal loss in rat brain. Neuroscience 1995; 69: 1095-1101.
15. Burlina AP, Ferrari V, Facci L, Skaper SD, Burlina AB. Mast cells contain large quantities of secretagogue-sensitive N-acetylaspartate. J Neurochem 1997; 69: 1314-1317.
16. Bhakoo KK, Pearce D. In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 2000; 74: 254-262.
17. Urenjak J, Williams SR, Gadian DG, Noble M. Specific expression of Nacetylaspartate in neurons, oligodendrocyte type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 1992; 59: 55-61.
18. Barker PB, Bryan RN, Kumar AJ, Naidu S. Proton NMR spectroscopy of Canavan’s disease. Neuropediatrics 1992; 23: 263-267.
19. Martin E, Capone A, Schneider J, Hennig J, Thiel T. Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy? Ann Neurol 2001; 49: 518-521.
20. Bizzi A, Ulug AM, Crawford TO, et al. Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2001; 22: 1125-1130.
21. Davie CA, Hawkins CP, Barker GJ, et al. Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet 1993; 341: 630-631.
22. 1H NMR markers of neuronal and glial disorders. NMR Biomed 1989; 2: 196-200.
23. Gill SS, Thomas DG, van Bruggen N, et al. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr 1990; 14: 497-504.
24. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992; 182: 19-27.
25. Stoll AL, Renshaw PF, De Micheli E, et al. Choline ingestion increases the resonance of cholinecontaining compounds in human brain: an in vivo proton magnetic resonance study. Biol Psychiatry 1995; 37: 170-174.
26. Ross BD, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994; 10: 191-247.
27. Stockler S, Holzbach U, Hanefeld F, et al. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res 1994; 36: 409-413.
28. Cecil KM, Salomons GS, Ball WS, Jr., et al. Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann Neurol 2001 Mar; 49: 401-404.
29. Bizzi A, Bugiani M, Salomons GS, et al. X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8. Ann Neurol 2002; 52: 227-231.
30. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neuroscience 1993; 13: 981-989.
31. Petroff OA, Graham GD, Blamire AM, et al. Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology 1992; 42: 1349-1354.
32. Barker PB, Gillard JH, van Zijl PC, et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 1994; 192: 723-732.
33. Alger JR, Frank JA, Bizzi A, et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990; 177: 633-641.
34. Mathews PM, Andermann F, Silver K, Karpati G, Arnold DL. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 1993; 43: 2484-2490.
35. 1H NMR in human visual cortex during physiologic stimulation. Proc Natl Acad Sci USA 1991; 88: 5829-5831.
36. Merboldt K-D, Bruhn H, Hanicke W, Michaelis T, Frahm J. Decrease of glucose in the human visual cortex during photic stimulation. Magn Reson Med 1992; 25: 187-194.
37. 1H NMR spectroscopy in the human visual cortex. J Cereb Blood Flow Metab 2007; 27: 1055-1063.
38. Mangia S, Tkac I, Logothetis NK, et al. Dynamics of lactate concentration and blood oxygen level-dependent effect in the human visual cortex during repeated identical stimuli. J Neurosci Res 2007; 85: 3340-3346.
39. Shonk TK, Moats RA, Gifford P, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 1995; 195: 65-72.
40. Al-Okaili RN, Krejza J, Wang S, Woo JH, Melhem ER. Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. Radiographics 2006; 26 (Suppl 1): S173-S189..
41. Kruse B, Hanefeld F, Christen HJ, et al. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo. J Neurol 1993; 241: 68-74.
42. Flogel U, Willker W, Leibfritz D. Regulation of intracellular pH in neuronal and glial tumour cells, studied by multinuclear NMR spectroscopy. NMR Biomed 1994; 7: 157-166.
43. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 289-298.
44. +/myo-inositol cotransport in rat cortical astrocytes. Glia 1994; 12: 35-43.
45. Lee JH, Arcinue E, Ross BD. Brief report: organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med 1994; 331: 439-442.
46. Videen JS, Michaelis T, Pinto P, Ross BD. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. J Clin Invest 1995; 95: 788-793.
47. 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med 2001; 46: 451-456.
48. Kreis R, Pfenninger J, Herschkowitz N, Boesch C. In vivo proton magnetic resonance spectroscopy in a case of Reye’s syndrome. Intensive Care Med 1995; 21: 266-269.
49. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. Energy on demand. Science 1999; 283: 496-497.
50. Sibson NR, Dhankhar A, Mason GF, et al. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci USA 1998; 95: 316-321.
51. van Zijl PCM, Barker PB. Magnetic resonance spectroscopy and spectroscopic imaging for the study of brain metabolism. Ann N Y Acad Sci 1997; 820: 75-96.
52. Terpstra M, Henry PG, Gruetter R. Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn Reson Med 2003; 50: 19-23.
53. 1H NMR measurements of gammaaminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 1993; 90: 5662-5666.
54. Pan JW, Telang FW, Lee JH, et al. Measurement of betahydroxybutyrate in acute hyperketonemia in human brain. J Neurochem 2001; 79: 539-544.
55. 1H-MRS in patients with epilepsy controlled by ketogenic diet. Magma 1999; 8: 33-42.
56. 1H magnetic-resonance spectroscopy. J Magn Reson B 1995; 107: 242-251.
57. van der Knaap MS, Wevers RA, Struys EA, et al. Leukoencephalopathy associated with a disturbance in the metabolism of polyols. Ann Neurol 1999; 46: 925-928.
58. Cady EB, Lorek A, Penrice J, et al. Detection of propan-1,2-diol in neonatal brain by in vivo proton magnetic resonance spectroscopy. Magn Reson Med 1994; 32: 764-767.
59. Meyerhoff DJ, Rooney WD, Tokumitsu T, Weiner MW. Evidence of multiple ethanol pools in the brain: an in vivo proton magnetization transfer study. Alcohol Clin Exp Res 1996; 20: 1283-1288.
60. Lin A, Nguy CH, Shic F, Ross BD. Accumulation of methylsulfonylmethane in the human brain: identification bymultinuclear magnetic resonance spectroscopy. Toxicol Lett 2001; 123: 169-177.
61. 1H magnetic resonance spectroscopy. Magn Reson Med 1995; 33: 862-867.
62. Bottomley PA [inventor General Electric Company, assignee]. Selective volume method for performing localized NMR spectroscopy. USA patent 4480228. October 30 1984.
63. Luyten PR, Marien AJ, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990; 176: 791-799.
64. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 1982; 79: 3523-3526.
65. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993; 188: 277-282.
66. Moonen CT, von Kienlin M, van Zijl PC, et al. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy. NMR Biomed 1989; 2: 201-208.
67. 1H-MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain. Magn Reson Med 1999; 41: 21-29.
68. Moonen CTW, Sobering G, van Zijl PCM, et al. Proton spectroscopic imaging of human brain. J Magn Reson 1992; 98: 556-575.
69. Gruetter R. Automatic, localized in vivo adjustment of all first-and second-order shim coils. Magn Reson Med 1993; 29: 804-811.
70. Sukumar S, Johnson MO, Hurd RE, van Zijl PC. Automated shimming for deuterated solvents using field profiling. J Magn Reson 1997; 125: 159-162.
71. 1H spectroscopic imaging in human brain by echo planar spatial-spectral encoding. Magn Reson Med 1995; 33: 34-40.
72. Duyn JH, Moonen CT. Fast proton spectroscopic imaging of human brain using multiple spin-echoes. Magn Reson Med 1993; 30: 409-414.
73. Dydak U, Weiger M, Pruessmann KP, Meier D, Boesiger P. Sensitivityencoded spectroscopic imaging. Magn Reson Med 2001; 46: 713-722.
74. 1H NMR chemical shift selective imaging. Phys Med Biol. 1985; 30: 341-344.
75. 1H NMR spectroscopy. J Magn Reson B 1994; 104: 1-10.
76. Moonen CTW, van Zijl PCM. Highly efficient water suppression for in vivo proton NMR spectroscopy. JMagnReson 1990; 88: 28-41.
77. Spielman DM, Pauly JM, Macovski A, Glover GH, Enzmann DR. Lipidsuppressed single-and multisection proton spectroscopic imaging of the human brain. J Magn Reson Imaging 1992; 2: 253-262.
78. 1H spectroscopic imaging by data extrapolation. Magn Reson Med 1996; 35: 678-687.
79. Raphael C. In vivo NMR spectral parameter estimation: a comparison between time and frequency domain methods. Magn Reson Med 1991; 18: 358-370.
80. 1H spectroscopic imaging data sets. NMR Biomed 1992; 5: 171-178.
81. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679.
82. Henriksen O. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS. NMR Biomed 1995; 8: 139-148.
83. Soher BJ, van Zijl PC, Duyn JH, Barker PB. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996; 35: 356-363.
84. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993; 187: 219-227.
85. Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson Ser B 1993; 102: 9-19.
86. Hetherington HP, Mason GF, Pan JW, et al. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1 T. Magn Reson Med 1994; 32: 565-571.
87. Breiter SN, Arroyo S, Mathews VP, et al. Proton MR spectroscopy in patients with seizure disorders. AJNR Am J Neuroradiol 1994; 15: 373-384.
88. Vermathen P, Ende G, Laxer KD, et al. Hippocampal N-acetyl aspartate in neocortical epilepsy and mesial temporal lobe epilepsy. Ann Neurol 1997; 42: 194-199.
89. Charles HC, Lazeyras F, Krishnan KRR, et al. Proton spectroscopy of human brain: effects of age and sex. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18: 995-1005.
90. van der Knaap MS, van der Grond J, van Rijen PC, et al. Age-dependent changes in localized proton and phosphorus MR spectrscopy of the brain. Radiology 1990; 176: 509-515.
91. 1Hspectroscopy in developing brain. Pediatric Res. 1991; 30: 574-578.
92. Kimura H, Fujii Y, Itoh S, et al. Metabolić Alterations in the neonate and infant brain during development: evaluation with proton MR spectroscopy. Radiology. 1995; 194: 483-489.
93. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993; 30: 424-437.
94. Pouwels PJ, Frahm J. Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed 1997; 10: 73-78.
95. Lim KO, Spielman DM. Estimating NAA in cortical gray matter with applications for measuring changes due to aging. Magn Reson Med 1997; 37: 372-377.
96. Christiansen P, Toft P, Larsson HBW, Stubgaard M, Henriksen O. The Concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn Reson Imaging 1993; 11: 799-806.
97. Chang L, Ernst T, Poland RE, Jenden DJ. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci 1996; 58: 2049-2056.
98. 1H spectroscopic imaging of normal and aging brain. Magn Reson Med 1999; 41: 841-845.